am 251 and quinpirole
am 251 has been researched along with quinpirole in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kreitzer, AC; Malenka, RC | 1 |
| Evers-Donnelly, A; Nicholson, D; O'Boyle, KM; O'Connor, JJ; O'Neill, C | 1 |
Other Studies
2 other study(ies) available for am 251 and quinpirole
| Article | Year |
|---|---|
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum.
Topics: Animals; Aspartic Acid; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cerebellum; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Radiation; Electric Stimulation; Endocannabinoids; Epistasis, Genetic; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Long-Term Synaptic Depression; Membrane Potentials; Methoxyhydroxyphenylglycol; Morpholines; Naphthalenes; Neurons; Nitrendipine; Patch-Clamp Techniques; Piperidines; Pyrazoles; Quinpirole; Rats; Rats, Sprague-Dawley; Sulpiride; Time Factors | 2005 |
D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: studies using fast cyclic voltammetry.
Topics: Animals; Benzoxazines; Dopamine; Dopamine Agonists; Electrochemistry; In Vitro Techniques; Ligands; Morpholines; Naphthalenes; Neostriatum; Piperidines; Pyrazoles; Quinpirole; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2 | 2009 |